Vertex Pharmaceuticals Incorporated (VRTX) Insider Trading
Over the last 3 months, VRTX insiders made 0 open-market buys and 7 sales, a net sale of -$5.4M (SEC Form 4). Over the last 6 months, 1383 institutions increased and 1243 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
7
Net (3m)
-$5.4M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price +23.4%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 23, 2026 | Sachdev Amitofficer: EVP Chief Patient & Ext Af Off | Grant | 8,251 | — |
| Jul 23, 2026 | Tatsis Ouraniaofficer: EVP, Chief Reg. & Quality Off. | Grant | 8,251 | — |
| Jul 17, 2026 | SACHS BRUCE Idirector | Grant | 100 | — |
| Jul 17, 2026 | Garber Alan Mdirector | Grant | 32 | — |
| Jul 7, 2026 | Tatsis Ouraniaofficer: EVP, Chief Reg. & Quality Off. | Sell | 1,500 | $524.99 |
| Jul 7, 2026 | McKechnie Duncanofficer: EVP, Chief Commercial Officer | Sell | 1,541 | $519.00 |
| Jul 6, 2026 | Liu Joyofficer: EVP and Chief Legal Officer | Sell | 828 | $502.71 |
| Jun 30, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 596 | $482.50 |
| Jun 23, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 1,020 | $462.17 |
| Jun 17, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 4,062 | $450.00 |
| Jun 9, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 1,745 | $450.00 |
| Jun 2, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 1,974 | $450.00 |
| May 19, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 1,354 | $453.45 |
| May 19, 2026 | Bunnage Mark E.officer: EVP, Chief Scientific Officer | Sell | 33 | $453.45 |
| May 14, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 6,988 | $450.00 |
| May 5, 2026 | Upadhyay Suketudirector | Grant | 796 | — |
| May 5, 2026 | Lagarde Micheldirector | Grant | 2,866 | $424.45 |
| May 5, 2026 | Thornberry Nancydirector | Grant | 472 | — |
| May 5, 2026 | Bhatia Sangeeta N.director | Sell | 318 | $423.73 |
| May 5, 2026 | MCKENZIE DIANAdirector | Grant | 943 | — |
| May 5, 2026 | Garber Alan Mdirector | Grant | 472 | — |
| May 5, 2026 | Schneider Jenniferdirector | Grant | 472 | — |
| May 5, 2026 | Thornberry Nancydirector | Grant | 398 | — |
| May 5, 2026 | Garber Alan Mdirector | Grant | 1,433 | $424.45 |
| May 5, 2026 | CARNEY LLOYDdirector | Grant | 2,866 | $424.45 |
| May 5, 2026 | Schneider Jenniferdirector | Grant | 796 | — |
| May 5, 2026 | SACHS BRUCE Idirector | Grant | 2,866 | $424.45 |
| May 5, 2026 | Thornberry Nancydirector | Grant | 1,433 | $424.45 |
| May 5, 2026 | Upadhyay Suketudirector | Grant | 2,866 | $424.45 |
| May 5, 2026 | Bhatia Sangeeta N.director | Grant | 943 | — |
Source: VRTX SEC Form 4 filings, latest Jul 23, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their VRTX positions over the last 6 months (SEC Form 13F).
Increased
1383
New positions
355
Reduced
1243
Sold out
114
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| Capital World Investors | Increased | 26.1M | Aug 12, 2026 |
| CAPITAL WORLD INVESTORS | Reduced | 25.4M | May 13, 2026 |
| BlackRock, Inc. | Increased | 24.1M | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 24.0M | May 13, 2026 |
| CAPITAL RESEARCH GLOBAL INVESTORS | Increased | 21.1M | May 13, 2026 |
| Capital Research Global Investors | Reduced | 19.5M | Aug 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 16.6M | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 16.5M | May 15, 2026 |
| STATE STREET CORP | Increased | 11.9M | Aug 7, 2026 |
| STATE STREET CORP | Increased | 11.7M | May 15, 2026 |
| Invesco Ltd. | Increased | 8.0M | Aug 14, 2026 |
| JPMORGAN CHASE & CO | Increased | 7.0M | May 13, 2026 |
| JPMORGAN CHASE & CO | Reduced | 6.5M | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 6.1M | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 6.0M | Aug 12, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.